Lates News

According to the documents disclosed by the Hong Kong Stock Exchange on August 21, Xie Bing increased his holdings of 29.87 million ordinary shares of China Biopharmaceuticals at an average price of HK$7.4382 per share on August 20, 2024, with a value of approximately HK$222 million. After the increase, Xie Bing's latest shareholding amount is 1.689 billion shares, and his equity ratio has increased from 8.84% to 9.00%.